An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Dose, Crossover, Oral Bioequivalence Study [of lamotrigine] in Healthy, Adult, Human Subjects Under Fed Conditions.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Lamotrigine (Primary)
- Indications Absence epilepsy; Bipolar disorders; Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- 01 Jul 2013 New trial record